New York, New York (PRWEB) July 01, 2014
Mirena lawsuits (http://www.themirenalawsuitcenter.com/) filed on behalf of women who were allegedly injured due to spontaneous migration of the birth control device continue to mount in courts throughout the U.S., Bernstein Liebhard LLP reports. According to court documents, a case filed last month in the U.S. District Court, Middle District of Tennessee alleges that Mirena complications stemming from migration of the IUD caused one young woman to suffer serious and permanent injuries. The Plaintiff, who had received her IUD in February 2010, was forced to undergo a surgical procedure in June 2013 to locate the device. The procedure revealed that the Mirena IUD had migrated, perforated her uterus and become embedded in her abdominal wall. Among other things, the woman claims that she was never warned of the risk of spontaneous migration associated with Mirena, and would never have used the IUD had she been made aware of this possibility. (Cherie Allen v. Bayer Healthcare Pharmaceuticals Inc., Case No. 3:14-cv-01318)
“Our Firm is representing numerous women in Mirena lawsuits who claim to have suffered injuries due to device migration that are very similar to the complications alleged in this complaint,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering free case evaluations to women who allegedly suffered serious Mirena complications including spontaneous migration of their IUD.
Mirena IUD Lawsuits
According to court documents, the Mirena IUD lawsuit filed in Tennessee is just one of more than 1,200 claims currently pending in state and federal courts throughout the U.S. These filings include more than 720 cases that are currently pending in a multicounty litigation underway in New Jersey’s Bergen County Superior Court, where Bernstein Liebhard LLP is actively filing claims. (In Re: Mirena Litigation; Case No. 297)
At least 569 additional Mirena lawsuits have been filed in a federal multidistrict litigation underway in U.S. District Court, Southern District of New York. (In re: Mirena IUD Products Liability Litigation, MDL No. 2434)
Court records indicate that all of these filings put forth similar allegations regarding the occurrence of serious Mirena complications related to spontaneous device migration, including uterine perforation, embedment in the uterine or abdominal wall, organ damage, adhesions and scarring, ectopic pregnancy and infertility. Among other things, plaintiffs claim that the labeling for the IUD only notes that the device may migrate if the uterus is perforated upon insertion. It does not mention that Mirena may migrate long after it was correctly inserted by a doctor. The complaints also allege that Bayer Healthcare Pharmaceuticals has a history of downplaying Mirena complications and overstating the benefits associated with the IUD.
The Mirena IUD was approved by the U.S. Food & Drug Administration (FDA) in 2000 as a method of contraception. In 2009, its approved uses were expanded to include the prevention of heavy menstrual bleeding in women who wish to use an IUD as their primary method of birth control. In 2009, Bayer Healthcare Pharmaceuticals was cited by the FDA for a marketing campaign that the agency said exaggerated the IUD's benefits and downplayed the risk of serious Mirena complications.
Alleged victims of serious Mirena complications related to spontaneous IUD migration may be entitled to compensation for their medical bills, lost wages, pain and suffering, and more. To learn more about the risks allegedly linked to spontaneous Mirena migration, please visit Bernstein Liebhard LLP's website, or the Firm's Facebook page: https://www.facebook.com/mirenalawsuithelp. For a free and confidential Mirena case review, please call 800-511-5092.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs' Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.
Bernstein Liebhard LLP represents the victims of defective drugs and medical devices on a contingency-fee basis, and our clients are never expected to pay attorneys fees unless their case results in a successful recovery on their behalf. New York State's contingency fee cap rules generally limit those fees to 33 1/3% of the total recovery. As a result, the Firm's fees can be significantly lower than those assessed by attorneys in other states, which depending on the law may amount to as much as 40% or more of a plaintiff's recovery.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com